Sound waves and antineoplastic drugs: The possibility of an enhanced combined anticancer therapy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kondo T, Kano E: The possibility of ultrasonic cancer therapy and some of the difficulties: implications of the thermal and nonthermal effects. Jpn J Hyperthermic Oncol 1990;6: 1–18.
Kondo T, Umemura S, Tanabe K, et al: Novel therapeutic application of ultrasound: utilization of thermal and cavitational effects. Jpn J Hyperthermic Oncol 2000;16: 203–216.
National Council on Radiation and Measurements: Historical Perspectives. In: Biological Effects of Ultrasound: Mechanisms and Clinical Implications. Report No. 74. Bethesda, Md: NCRP 1983; pp. 5–6.
Hill CR: Cited by: Kremkau FW. Cancer therapy with ultrasound: a historical review.J Clin Ultrasound 1979;7: 287–300.
Chen L, Rivens I, ter Haar G, et al: Histological changes in rat liver tumors treated with high-intensity focused ultrasound.Ultrasound Med Biol 1990;19: 67–74.
Riesz P, Kondo T: Free radical formation induced by ultrasound and its biological implications. Free Radic Biol Med 1992;13: 247–270.
Nyborg WL: Mechanisms. In: Nyborg, WL and Ziskin, MC, eds. Biological Effects of Ultrasound. New York, Churchil Livingstone, 1985; pp. 23–33.
Saad A, Hahn G: Ultrasound enhanced drug toxicity on Chinese hamster ovary cells in vitro.Cancer Res 1989;49: 5931–5934.
Loverock P, ter Haar G, Ormerod M, et al: The effect of ultrasound on the cytotoxicity of adriamycin.Br J Radiol 1990;63: 542–546.
Harrison G, Balcer-Kubiczek E, Gutierrez P: In vitro action of continuous-wave ultrasound combined with adriamycin, x-rays or hyperthermia.Radiat Res 1996;145: 98–101.
Umemura S, Yumita N, Okano Y, et al: Sonodynamically-induced in vitro cell damage enhanced by adriamycin.Cancer Lett 1997;121: 195–201.
Yumita N, Kaneuchi M, Okano Y, et al: Sonodynamically induced cell damage with 4'-O-tetrahydropyranyladriamycin, THP.Anticancer Res 1999;19: 281–284.
Tachibana K, Uchida T, Tamura K, et al: Enhanced cytotoxic effect of Ara-C by low intensity ultrasound to HL-60 cells.Cancer Lett 2000;147: 189–194.
Hering ER, Shepstone BJ: Observations on the combined effect of ultrasound and certain cytoxics on the growth of the roots of Zea mays.Br J Radiol 1977;50: 32–37.
Umemura S, Yumita N, Nishigaki R: Enhancement of ultrasonically induced cell damage by a galliumporphyrin complex, ATX-70. Jpn J Cancer Res 1993;84: 582–588.
Umemura S, Yumita N, Nishigaki R, et al: Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Jpn J Cancer Res 1990;81: 962–966.
Yumita N, Nishigaki R, Umemura K, et al: Hematoporphyrin as a sensitizer of cell-damaging effect of ultrasound. Jpn J Cancer Res 1989;80: 219–222.
Miyoshi N, Misik V, Riesz P: Sonodynamic toxicity of gallium-porphyrin analogue ATX-70 in human leukemia cells.Radiat Res 1997;148: 43–47.
Uchida T, Tachibana K, Hisano S, et al: Elimination of adult T cell leukemia cells by ultrasound in the presence of porfimer sodium.Anticancer Drugs 1997;8: 329–335.
Tachibana K, Uchida T, Hisano S, et al: Eliminating adult T-cell Leukaemia cells by ultrasound.Lancet 1997;349: 325.
Yumita N, Umemura S, Nishigaki R: Ultrasonically induced cell damage enhanced by photofrin II: mechanism of sonodynamic activation. In Vivo 2000;14: 425–430.
Umemura S, Yumita N, Umemura K, et al: Sonodynamically induced effect of rose Bengal on isolated sarcoma 180 cells.Cancer Chemother Pharmacol 1999;43: 389–393.
Yumita N, Umemura S, Kaneuchi M, et al: Sonodynamically-induced cell damage with fluorinated anthracycline derivative, FAD 104.Cancer Lett 1998;125: 209–214.
Sakusabi N, Okada K, Sato K, et al: Enhanced sonodynamic antitumor effect of ultrasound in the presence of nonsteroidal anti-inflammatory drugs. Jpn J Cancer Res 1999;90: 1146–1151.
Ward M, Wu J, Chiu JF: Ultrasound-induced cell lysis and sonoporation enhanced by contrast agents.J Acoust Soc Am 1999;105: 2951–2957
Yumita N, Okumura A, Nishigaki R, et al: The combination treatment of ultrasound and antitumor drugs on Yoshida sarcoma. Jpn J Hyperthermic Oncol 1987;3: 175–182.
Saad A, Hahn G: Ultrasound-enhanced effects of adriamycin against murine tumors.Ultrasound Med Biol 1992;18: 715–723.
Yang R, Reilly CR, Rescorla FJ, et al: Effects of high-intensity focused ultrasound in the treatment of experimental neuroblastoma.J Pediatr Surg 1992;27: 246–150.
Yang R, Reilly CR, Rescorla FJ, et al: High-intensity focused ultrasound in the treatment of experimental liver cancer.Arch Surg 1991;126: 1009–1010.
More W, Lopez RM, Matthews DE, et al: Evaluation of high-intensity therapeutic ultrasound irradiation in the treatment of experimental hepatoma.J Pediatr Surg 1989;24: 30–33.
Longo F, Tomashefsky P, Rivin B, et al: Interaction of ultrasonic hyperthermia with two alkylating agents in a murine bladder tumor.Cancer Res 1983;43: 3231–3235.
Senapati N, Houchens D, Ovejera A, et al: Ultrasonic hyperthermia and drugs as therapy for human tumor xenografts.Cancer Treat Rep 1982;66: 1635–1639.
Tacker J, Anderson R: Delivery of antitumor drug to bladder cancer by use of phase transition liposomes and hyperthermia.J Urol 1982;127: 1211–1214.
Elkon D, Lacher DA, Rinehart L, et al: Effect of ultrasound-induced hyperthermia and cisdiamminedichloride platinum II on murine renal function.Cancer 1982;49: 25–29.
Yumita N, Sasaki K, Umemura S, et al: Sonodynamically induced antitumor effect of galliumporphyrin complex by focused ultrasound on experimental kidney tumor.Cancer Lett 1996;112: 79–86.
Jin Z, Miyoshi N, Ishiguro K, et al: Combination effect of photodynamic and sonodynamic therapy on experiemntal skin squamous cell carcinoma in C3H/HeN mice.J Dermatol 2000;27: 294–306.
Yumita N, Sasaki K, Umemura S, et al: Sonodynamically induced antitumor effect of galliumporphyrin complex by focused ultrasound on experimental kidney tumor:Cancer Lett 1997;112: 79–86.
Sasaki K, Yumita N, Nishigaki R, et al: Antitumor effect sonodynamically induced by focused ultrasound in combination with Ga-porphyrin complex. Jpn J Cancer Res 1998;89: 452–456.
Yumita N, Nishigaki R, Umemura S: Sonodynamically induced antitumor effect of Photofrin II on colon 26 carcinoma.J Cancer Res Clin Oncol 2000;126: 601–606.
Sur P, Ghosh P, Bag SP, et al: On the inhibitory activities of a new boron compound and ultrasound against the mouse ascites tumour.Chemotherapy 1999;45: 360–369.
Kremkau FW, Kaufmann JS, Walker MM, et al: Ultrasonic enhancement of nitrogen mustard cytotoxicity in mouse leukemia.Cancer 1976;37: 1643–1647.
Harrison G, Balcer-Kubiczek EK, Eddy HA: Potentiation of chemotherapy by low-level ultrasound.Int J Radiat Biol 1991;59: 1453–1466.
Yumita N, Nishigaki R, Sakata I, et al: Sonodynamically induced antitumor effect of 4-formyloximethylidene-3-hydroxy-2-vinyl-deuterio-porphynyl (IX)-6,7-diaspartic acid (ATX-S10). Jpn J Cancer Res 2000;91: 255–260.
Umemura K, Yumita N, Nishigaki R, et al: Sonodynamically induced antitumor effect of pheophorbide a.Cancer Lett 1996;102: 151–157.
Brayman AA, Coppage ML, Vaidya S, Miller MW: Transient poration and cell surface receptor removal from human lymphocytes in vitro by 1 MHz ultrasound.Ultrasound Med Biol 1999;25: 999–1008.
Tachibana K, Uchida T, Ogawa K, et al: Induction of cell membrane porosity by ultrasound.Lancet 1999;353: 1409.
Hahn GM, Braun J, Har-Kedar I: Thermochemotherapy: synergism between hyperthermia (42–43 degrees) and adriamycin (or bleomycin) in mammalian cell inactivation.Proc Natl Acad Sci USA 1975;72: 937–940.
Kondo T, Kano E: Enhancement of hyperthermic cell killing by non-thermal effect of ultrasound.Int J Fadiat Biol 1987;51: 157–166.
Longo FW, Longo WE, Tomashefsky P, et al: Interaction of ultrasound with neoplastic tissue. Local effect on subcutaneously implanted Furth-Columbia rat Wilm's tumor.Urology 1975;6: 631–634.
Yumita N, Umemura S, Magario N, et al: Membrane lipid peroxidation as a mechanism of sonodynamically induced erythrocyte lysis.Int J Radiat Biol 1996;69: 397–404.
Kondo T, Kano E: Effect of free radicals induced by ultrasonic cavitation on cell killing.Int J Radiat Biol 1988;54: 437–486.
Hristov PK, Petrov LA, Russanov EM: Lipid peroxidation induced by ultrasound in Ehrlich ascitis tumor cells.Cancer Lett 1997;121: 7–10.
Kessel D, Jeffers R, Fowlkes JB, et al: Effects of sonodynamic and photodynamic treatment on cellular thiol levels.J Photochem Photobiol B: Biol 1996;32: 103–106.
Russo A, Mitchell JB: Potentiation and protection of doxorubicin cytotoxicity by cellular glutathione modulation.Cancer Treat Rep 1985;69: 1293–1296.
Tata D, Hahn G, Dunn F: Ultrasonic absorption frequency dependence of two widely used anti-cancer drugs: doxorubicin and daunorubicin.Ultrasonics 1993;31: 447–450.
Misik V, Riesz P: Free radical intermediates in sonodynamic therapy.Ann N Y Acad Sci 2000;899; 335–348.
Misik V, Riesz P: Peroxyl radical formation in aqueous solutions of N,N-dimethylformamide, N-methylformamide, and dimethylsulfoxide by ultrasound: implications for sonosensitized cell killing.Free Radic Biol Med 1996;20: 129–138.
Riesz P, Kondo T, Krishna MC: Free radical formation by ultrasound in aqueous solutions: a spin trapping study.Free Radic Res Comms 1990;10: 27–35.
Sinha BK, Mimnaugh EG: Free radical and anticancer drug resistance: oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors.Free Radic Biol Med 1990;8: 567–581.
Naffrechoux E, Chanoux S, Petrier C, et al: Sonochemical and photochemical oxidation of organic matter. Ultrason Sonochem 2000;7: 255–259.
Worthington AE, Thompson J, Rauth AM, Hunt JW: Mechanism of ultrasound enhanced porphyrin cytotoxicity. Part I: A search for free radical effects.Ultrasound Med Biol 1997;23: 1095–1105.
Simon R, Ho SY, Lange S, et al: Applications of lipid-coated microbubble ultrasonic contrast to tumor therapy.Ultrasound Med Biol 1993;19: 123–125.
Tata D, Biglow J, Wu J, et al: Ultrasound-enhanced hydroxyl radical production from two clinically employed anticancer drugs, adriamycin and mitomycin C.Ultrason Sonochem 1996;3: 39–45.
Lusthof KJ, de Mol NJ, Richter W, et al: Redox cycling of potential antitumor aziridinyl quinones.Free Radic Biol Med 1992;13: 599–608.
Misik V, Miyoshi N, Riesz P: EPR spin trapping study of the decomposition of azo compounds in aqueous solutions by ultrasound: potential for use as sonodynamic sensitizers for cell killing.Free Radic Res 1996;25: 13–22.
Kapp DS, Hahn GM: Thermosensitization by sulfhydryl compounds of exponential growing Chinese hamster cells.Cancer Res 1979;39: 4630–4635.
Marmor JB, Kozak D, Hahn GM: Effects of systemically administered bleomycin or adriamycin with local hyperthermia on primary tumor and lung metastases. Cancer Treat Rep 1979;63: 1279–1290.
Hahn GM: Potential for therapy of drugs and hyperthermia.Cancer Res 1979;39: 2264–2268.
Barlogie B, Corry PM, Drewinko B: In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum (II) and mitomycin C.Cancer Res 1980;40: 1165–1168.
Braun J, Hahn GM: Enhanced cell killing by bleomycin and 43 degrees hyperthermia and the inhibition of recovery from potentially lethal damage.Cancer Res 1975;35: 2921–2927.
Umemura S, Kawabata K, Sasaki K, et al: Recent advances in sonodynamic approach to cancer therapy.Ultrason Sonochem 1996;3: S188-S1191.
Shen RN, Lu L, Wu B, et al: Effects of interleukin 2 treatment combined with local hyperthermia in mice inoculated with Lewis lung carcinoma cells.Cancer Res 1990;50: 5027–5030.
Cheng SQ, Zhou XD, Tang ZY, et al: Iodized oil enhances the thermal effect of high-intensity focused ultrasound on ablating experimental liver cancer.J Cancer Res Clin Oncol 1997;123: 639–644.
Feril Jr. L, Kondo T, Zhao QL, et al: Enhancement of hyperthermia-induced apoptosis by nonthermal effects of ultrasound.Cancer Lett 2002;178: 63–70.
Kim SH, Kim JH, Hahn EW: Selective potentiation of hyperthermic killing of hypoxic cells by 5-thio-D-glucose.Cancer Res 1978;38: 2935–2938.
Knapp W, Debatin J, Helus F, et al: Increased thermal response to ultrasound in the Walker carcinosarcoma treated with vasoactive drugs.Cancer Res 1989;49: 1768–1772.
Berthold F, Berthold R, Matter I, et al: Effect of spleen exposure to ultrasound on cellular and antibody-mediated immune reactions in man. Immunol 1982;162: 46–55.
Sietses C, Eijsbouts QAJ, von Blomberg BM, et al: Ultrasonic energy vs. monopolar electrosurgery in laparoscopic cholecystectomy: influence on the postoperative systemic immune response.Surg Endosc 2001;15: 69–71.
Stewart HF, Moore Jr RM: Development of health risk evaluation data for diagnostic ultrasound: a historical perspective.J Clin Ultrasound 1984;12: 493–500.
Child SZ, Hare JD, Carstensen EL, et al: Test for the effects of diagnostic ultrasound on the immune response of mice. Clin Immunol Immunopathol 1981;18: 299–302.
Miller MW, Miller DL, Brayman AA: A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective.Ultrasound Med Biol 1996;22: 1131–1154.
Worle K, Steinbach P, Hofstadter F: The combined effects of high-energy shock waves and cytostatic drugs or cytokines on human bladder cancer cells.Br J Cancer 1994;69: 58–65.
Rahman M: In vitro effects of high energy shock wave alone and combined with anticancer drugs on human bladder cancer cells.Urol Int 1994;53: 12–17.
Wilmer A, Gambihler S, Delius M, Brendel W: In vitro cytotoxic activity of lithotripter shock waves combined with adriamycin or with cisplatin on L 1210 mouse leukemia cells.J Cancer Res Clin Oncol 1989;115: 229–234.
Oosterhof GO, Smits GA, de Ruyter JE, et al: The in vitro effect of electromagnetically generated shock waves (Lithostar) on the Dunning R 3327 PAT-2 rat prostatic cancer cell-line: a potentiating effect on the in vitro cytotoxicity of vinblastin.Urol Res 1989;17: 13–19.
Prat F, Sibille A, Luccioni C, et al: Increased chemocytotoxicity to colon cancer by shock wave-induced cavitation.Gastroenterology 1994;106: 937–944.
Oosterhof GO, Smits GA, de Ruyter AE, et al: In vivo effects of high energy shock waves on urological tumors: an evaluation of treatment modalities.J Urol 1990;144: 785–789.
Weiss N, Delius M, Gambihler S, et al: Effect of shock waves and cisplatin on cisplatin-sensitive and-resistant rodent tumors in vivo.Int J Cancer 1994;58: 693–699.
Maruyama M, Asano T, Uematsu T, et al: The effect of high-energy shock wave therapy combined with cisplatin on mouse hepatoma. Jpn J Surg 1995;25: 987–988.
Hoshi S, Orikasa S, Kuwahara M, et al: Shock wave and THP-adriamycin for treatment of rabbit's bladder cancer. Jpn J Cancer Res 1992;83: 248–250.
Kato M, Ioritani N, Suzuki T, et al: Mechanism of anti-tumor effect of combination of bleomycin and shock waves. Jpn J Cancer Res 2000;91: 1065–1072.
Oosterhof GO, Smits GA, de Ruyter AE, et al: Effects of high-energy shock waves combined with biological response modifiers in different human kidney cancer xenografts.Ultrasound Med Biol 1991;17: 391–399.
Hoshi S, Orikasa S, Suzuki K, et al: High-energy underwater shock wave treatment for internal iliac muscle metastasis of prostatic cancer: a first clinical trial. Jpn J Cancer Res 1995;86: 424–428.
Kambe M, Ioritani N, Shirai S, et al: Enhancement of chemotherapeutic effects with focused shock waves: extracorporeal shock wave chemotherapy (ESWC).In Vivo 1996;10: 369–375.
Randazzo RF, Chaussy CG, Fuchs GJ, et al: The in vitro and in vivo effects of extracorporeal shock waves on malignant cells.Urol Res 1988;16: 419–426.
Kambe M, Ioritani N, Kanamaru R: Enhancement of chemotherapeutic effects with focused shock waves: extracorporapeureal shock wave chemotherapy (ESWC).Hum Cell 1997;10: 87–93.
Delius M, Adams G: Shock wave permeabilization with ribosome inactivating proteins: a new approach to tumor therapy.Cancer Res 1999;59: 5227–5232.
Suzuki K, Orikasa S, Hoshi S, et al: Shock wave therapy of the rabbit VX 2 bladder cancer-THP-ADM concentration in the tissue after combination therapy of THP-AD M and shock wave [in Japanese]. Nippon Hinyokika Gakkai Zasshi 1993;84: 1007–1012. Abstract in English.
Keizer HG, Pinedo HM, Schuurhuis GJ, Joenje H: Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity.Pharmacol Ther 1990;47: 219–231.
Fosmire H, Hynynen K, Drach GW, et al: Feasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1993;26: 253–259.
Gelet A, Chapelon JY, Bouvier R, et al: Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience.Eur Urol 1996;29: 174–183.
Gelet A, Chapelon JY, Bouvier R, et al: Local control of prostate cancer by transrectal high intensity focussed ultrasound therapy: preliminary results.J Urol 1999;161: 156–162.
Beerlage HP, van Leenders GJ, Oosterhof GO, et al: High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study.Prostate 1999;39: 41–46.
Gelet A, Chapelon JY, Bouvier R, et al: Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer.J Endourol 2000;14: 519–528.
Hurwitz MD, Kaplan ID, Svensson GK, et al: Feasibility and patient tolerance of a novel transrectal ultrasound hyperthermia system for treatment of prostate cancer.Int J Hyperthermia 2001;17: 31–37.
Uchida T, Sanghvi NT, Gardner TA, et al: Transcretal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report.Urology 2002;59: 394–398.
Beerlage HP, Thuroff S, Debruyne FM, et al: Transcrectal high-intensity ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma.Urology 1999;54: 273–277.
Madersbacher S, Kratzik C, Susani M, et al: Transcutaneous high-intensity focused ultrasound and irradiation: an organ-preserving treatment of cancer in a solitary testis.Eur Urol 1998;33: 195–201.
Vallancien G, Harouni M, Guillonneau B, et al: Ablation of superficial bladder tumors with focused extracorporial pyrotherapy.Urology 1996;47: 204–207.
Myerson RJ, Straube WL, Moros EG, et al: Simultaneous superficial hyperthermia and external radiotherapy: report of thermal dosimetry and tolerance to treatment.Int J Hyperthermia 1999;15: 251–266.
Guthkelch AN, Carter LP, Cassady JR, et al: Treatment of malignant brain tumors with focused ultrasound hyperthermia and radiation: results of a phase I trial.J Neurooncol 1991;10: 271–284.
van Dam PA, Tjalma W, Weyler J, et al: Ultraradical debulking of epithelial ovarian cancer with the ultrasonic surgical aspirator: a prospective randomized trial.Am J Obstet Gynecol 1996;174: 943–950.
Rosberger DF, Coleman DJ, Silverman R, et al: Immunomodulation in choroidal melanoma: reversal of inverted CD 4/CD 8 ratios following treatment with ultrasonic hyperthermia. Biotechnol Ther 1994;5: 59–68.
Visioli AG, Rivens IH, ter Haar GR, et al: Preliminary results of a phase I dose escalation clinical trial using focused ultrasound in the treatment of localized tumours.Eur J Ultrasound 1999;9: 11–18.